Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) join forces with small and medium-sized enterprises (SMEs) and academia in an Innovative Medicines Initiative (IMI) supported public private partnership project to establish the leading facility for the storage and distribution of induced pluripotent stem (iPS) cells in Europe.
Roslin Cells announced today that ReNeuron would be the first commercial customer for its new GMP Cellular Therapy Manufacturing Facility in Edinburgh.
Cell Therapy Catapult & Roslin Cells to create clinical grade stem cells to accelerate research into new treatments
The Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation's health and wealth, and Roslin Cells, an expert in the production of stem cells, are partnering to establish a source of clinical grade induced pluripotent stem cells (iPS) banked according to Good Manufacturing Practice (GMP) in the UK.
Roslin Cells is Granted an MIA(IMP) and Manufacturer's 'Specials' Licence for Cellular Therapy Facility
Roslin Cells Ltd, announced today that its GMP Cellular Therapy Manufacturing Facility within the Scottish Centre for Regenerative Medicine has recently been licensed by the Medicines Healthcare Products Regulatory Agency (MHRA) for the manufacture of human cell therapy products.
Roslin Cells Ltd, world leaders in the development of cell therapies and pluripotent stem cells for applications in research, drug discovery and therapy, has achieved the prestigious Investors in People Accreditation.
The video below focusses on the groundbreaking research being conducted within the MRC Centre for Regenerative Medicine (CRM). Roslin Cells is co-located with the CRM at the new Scottish Centre for Regenerative Medicine opened on 28th May by HRH, The Princess Royal, Chancellor of the University.
Within the video you will see footage of our state of the art GMP Cellular Therapy Facility which we operate in partnership with the Scottish National Blood Transfusion Service.
The Scottish Centre for Regenerative was officially opened today (28th May 2012) by HRH, The Princess Royal.
Download our New Brochure
Roslin Cells Ltd, announced today that it will be participating in a consortium to generate human induced pluripotent stem cells (iPS cells) to study bipolar affective disorder.